Transparency is the key to the creation of confidence in relations with the general public and patients. That is why Mylan GmbH, BGP Products GmbH and MEDA Pharma GmbH intend in future to disclose the pecuniary benefits provided between the pharmaceutical industry and stakeholders in the healthcare sector on this site.

Additional information can be found at:
www.en.scienceindustries.ch/involvement/pharma-code-and-pharma-cooperation-code/disclosure-obligation

Methodological Note

BGP Products GmbH:
Report 2015
Report 2016
Report 2017

MEDA Pharma GmbH:
Report 2017